[Involvement of matrix metalloproteinases in acute coronary syndrome (ACS)].

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Gaceta Médica de México

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 24276189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence.

  2013cited by this paper
• The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients.

  2012cited by this paper
• The Association of Serum Neutrophil Markers and Acute Coronary Syndrome

  2012cited by this paper
• Molecular mechanisms regulating matrix metalloproteinases.

  2012cited by this paper
• Single nucleotide polymorphism –799C/T in matrix metalloproteinase-8 promoter region in arterial disease

  2012cited by this paper
• The Role of Matrix Metalloproteinase-2 Promoter Polymorphisms in Coronary Artery Disease and Myocardial Infarction

  2011cited by this paper
• [Epidemiology of acute coronary syndrome and heart failure in Latin America].

  2011cited by this paper
• Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study.

  2011cited by this paper
• Matrix metalloproteinas-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease

  2011cited by this paper
• Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.

  2010cited by this paper
• Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck

  2010cited by this paper
• Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer

  2010cited by this paper
• Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics.

  2009cited by this paper
• Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population

  2009cited by this paper
• Association of matrix metalloproteinase-2 gene promoter polymorphism with myocardial infarction susceptibility in a Mexican population

  2009cited by this paper
• A Role of Matrix Metalloproteinase-8 in Atherosclerosis

  2009cited by this paper
• Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.

  2008cited by this paper
• Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study

  2008cited by this paper
• Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

  2007cited by this paper
• Polymorphisms in MMP Family and TIMP Genes and Carotid Artery Intima-Media Thickness

  2007cited by this paper
• The Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) Interacts with Membrane Type 1 Matrix Metalloproteinase and CD13/Aminopeptidase N and Modulates Their Endocytic Pathways*

  2007cited by this paper
• Matrix metalloproteinase-8: cleavage can be decisive.

  2006cited by this paper
• Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

  2005cited by this paper
• Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction

  2005cited by this paper
• Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.

  2005cited by this paper
• Stromelysin‐1 promoter 5A/6A polymorphism is an independent genetic prognostic risk factor and interacts with smoking cessation after index premature myocardial infarction

  2005cited by this paper
• Elevated circulating levels of matrix metalloproteinase‐9 and ‐2 in patients with symptomatic coronary artery disease

  2005cited by this paper
• MMP-1: the elder of the family.

  2005cited by this paper
• Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction

  2005cited by this paper
• Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population

  2004cited by this paper
• Distinct Roles for the Catalytic and Hemopexin Domains of Membrane Type 1-Matrix Metalloproteinase in Substrate Degradation and Cell Migration*

  2004cited by this paper
• Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

  2004cited by this paper
• Induction of the MMP-14 Gene in Macrophages of the Atherosclerotic Plaque: Role of SAF-1 in the Induction Process

  2004cited by this paper
• Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction

  2003cited by this paper
• Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese.

  2003cited by this paper
• A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression.

  2003cited by this paper
• Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?

  2003cited by this paper
• Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.

  2003cited by this paper
• Two MMP-2 Promoter Polymorphisms (–790T/G and –735C/T) in Chronic Heart Failure

  2003cited by this paper
• Inhibition of Matrix Metalloproteinases Prevents Cardiac Hypertrophy Induced by &bgr;-Adrenergic Stimulation in Rats

  2003cited by this paper
• Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease

  2003cited by this paper
• Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.

  2003cited by this paper
• Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.

  2003cited by this paper
• Matrix metalloproteinases: a tail of a frog that became a prince

  2002cited by this paper
• Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease

  2002cited by this paper
• Increased Expression of Membrane Type 3-Matrix Metalloproteinase in Human Atherosclerotic Plaque: Role of Activated Macrophages and Inflammatory Cytokines

  2002cited by this paper
• Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men.

  2002cited by this paper
• MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males.

  2002cited by this paper
• Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.

  2002cited by this paper
• Prediction of the risk of myocardial infarction from polymorphisms in candidate genes.

  2002cited by this paper
• Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study

  2001cited by this paper
• Transforming growth factor‐β suppresses tumor necrosis factor α‐induced matrix metalloproteinase‐9 expression in monocytes

  2001cited by this paper
• Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis

  2001cited by this paper
• Manganese Superoxide Dismutase Signals Matrix Metalloproteinase Expression via H2O2-dependent ERK1/2 Activation*

  2001cited by this paper
• Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 Gene

  2001cited by this paper
• Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors

  2001cited by this paper
• Allele-Specific Regulation of Matrix Metalloproteinase-7 Promoter Activity Is Associated With Coronary Artery Luminal Dimensions Among Hypercholesterolemic Patients

  2001cited by this paper
• Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.

  2000cited by this paper
• Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury.

  2000cited by this paper
• Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.

  2000cited by this paper
• Coronary heart disease epidemiology in the 21st century.

  2000cited by this paper
• Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription.

  2000cited by this paper
• Tissue inhibitors of metalloproteinases: evolution, structure and function.

  2000cited by this paper
• Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways.

  2000cited by this paper
• Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.

  2000cited by this paper
• Macrophage‐derived MT1‐MMP and increased MMP‐2 activity are associated with glomerular damage in crescentic glomerulonephritis

  2000cited by this paper
• Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.

  1999cited by this paper
• Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling.

  1999cited by this paper
• The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group.

  1999cited by this paper
• The natural course of atherosclerosis. Part I: incidence and progression.

  1999cited by this paper
• The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells*

  1999cited by this paper
• Mammalian Krüppel-like transcription factors: more than just a pretty finger.

  1999cited by this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cited by this paper
• Human stromelysin gene promoter activity is modulated by transcription factor ZBP‐89

  1999cited by this paper
• Immunolocalization and gene expression of matrilysin during corneal wound healing.

  1999cited by this paper
• The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

  1999cited by this paper
• Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.

  1999cited by this paper
• Early Activation of Metalloproteinases after Experimental Myocardial Infarction Occurs in Infarct and Non-infarct Zones.

  1998cited by this paper
• Differential Effects of Transforming Growth Factor-β on the Expression of Collagenase-1 and Collagenase-3 in Human Fibroblasts*

  1998cited by this paper
• Matrix metalloproteinases: structures, evolution, and diversification

  1998cited by this paper
• A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.

  1998cited by this paper
• Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells*

  1997cited by this paper
• Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase*

  1997cited by this paper
• Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme.

  1996cited by this paper
• Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression*

  1996cited by this paper
• Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation

  1996cited by this paper
• Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein.

  1996cited by this paper
• Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3.

  1996cited by this paper
• Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

  1996cited by this paper
• Human Macrophage Metalloelastase. GENOMIC ORGANIZATION, CHROMOSOMAL LOCATION, GENE LINKAGE, AND TISSUE-SPECIFIC EXPRESSION (*)

  1995cited by this paper
• The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family.

  1995cited by this paper
• Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina.

  1995cited by this paper
• Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells

  1995cited by this paper
• Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

  1994cited by this paper
• Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages.

  1993cited by this paper
• Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

  1991cited by this paper
• The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene

  1991cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper

• Possible role of intronic polymorphisms in the PHACTR1 gene on the development of cardiovascular disease.

  2016cites this paper
• Inflammation, Metalloproteinases, Chronic Venous Disease and Sulodexide

  2015cites this paper